US 12246014
Azetidine derivatives
granted A61KA61K31/397A61K31/4427
Quick answer
US patent 12246014 (Azetidine derivatives) held by Ligand UK Development Limited expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ligand UK Development Limited
- Grant date
- Tue Mar 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/397, A61K31/4427, A61K31/4439, A61K31/495